NCCN 2015 Congress Webinar Series: Breast Cancer with Updates with from 2014 SABCS - Management of Patients with Metastatic Disease
As the complexity and importance of screening, testing, and individualized treatment strategies for breast cancer have increased, so has clinicians’ reliance on the National Comprehensive Cancer Network (NCCN) Breast Cancer Guidelines and NCCN’s educational interventions to increase knowledge and bridge the gaps between knowledge and competence.
This webinar series will provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines for Breast Cancer, to ensure that oncologists and other oncology healthcare professionals have a clear understanding of breast cancer diagnosis, staging and initial therapy; radiation therapy in the management of locoregional disease; adjuvant therapy for locoregional disease; and metastatic disease management.
This educational program is designed to meet the educational needs of oncologists, nurses, pharmacists, and other health care professionals who manage patients with breast cancer.
Following this activity, participants should be able to:
- Evaluate therapeutic options for patients with metastatic breast cancer based on recently available clinical trial evidence and current guidelines recommendations
- Discuss clinical trial participation with appropriate patients based on an awareness of current clinical trials in metastatic breast cancer
William J. Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
This activity is approved for AMA PRA Category 1 Credit(s)™ for physicians and also accredited for nurses and pharmacists (ACPE). View complete accreditation information
Some restrictions may apply: Any attendees that claimed credit for attending the live, in-person NCCN 2015 Congress Series™: Breast Cancer in Chicago, IL, on Februrary 13, 2015, may not claim credit for this webinar.
- 1.25 Participation
- 1.25 Nurse
- 1.25 Pharmacist
- 1.25 Physician